Glaxo Raises Human Genome Offer

Glaxo Raises Human Genome Offer Play

GlaxoSmithKline Plc raised its hostile takeover offer for Human Genome Sciences Inc. to about $14 a share, Reuters reported, citing two people familiar with the situation.

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus